0001140361-17-012956.txt : 20170322
0001140361-17-012956.hdr.sgml : 20170322
20170322172041
ACCESSION NUMBER: 0001140361-17-012956
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170321
FILED AS OF DATE: 20170322
DATE AS OF CHANGE: 20170322
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REPLIGEN CORP
CENTRAL INDEX KEY: 0000730272
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 042729386
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 7814499560
MAIL ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DAWES KAREN A
CENTRAL INDEX KEY: 0001261506
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-14656
FILM NUMBER: 17707505
MAIL ADDRESS:
STREET 1: 579 BELLEVUE AVE
CITY: NEWPORT
STATE: RI
ZIP: 02840
4
1
doc1.xml
FORM 4
X0306
4
2017-03-21
0
0000730272
REPLIGEN CORP
RGEN
0001261506
DAWES KAREN A
C/O REPLIGEN CORPORATION
41 SEYON STREET, BLDG 1, STE 100
WALTHAM
MA
02453
1
0
0
0
Common Stock
2017-03-21
4
M
0
20000
4.29
A
95764
D
Common Stock
2017-03-21
4
S
0
2521
34.1201
D
93243
D
Stock Option (Right to Buy)
4.29
2017-03-21
4
M
0
20000
0
D
2017-09-14
Common Stock
20000
0
D
$34.1201 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.10 to $34.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
This option is currently exercisable.
/s/ Jeffrey P. Leduc (Attorney in Fact)
2017-03-22